These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6590017)

  • 41. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oestrogen and progesterone receptor distribution in the cancerous breast.
    Panahy C; Puddefoot JR; Anderson E; Vinson GP; Berry CL; Turner MJ; Brown CL; Goode AW
    Br J Cancer; 1987 Apr; 55(4):459-62. PubMed ID: 3580270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
    Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
    Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activated oestrogen receptors in breast cancer and response to endocrine therapy.
    Fernandez MD; Burn JI; Sauven PD; Parmar G; White JO; Myatt L
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):41-6. PubMed ID: 6537914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic significance of progesterone receptor in breast cancer].
    He LW
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):121-3. PubMed ID: 2806040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
    Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
    Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical evaluation of estrogen and progesterone receptors of pre and post-neoadjuvant chemotherapy for breast cancer.
    Pachnicki JP; Czeczko NG; Tuon F; Cavalcanti TS; Malafaia AB; Tuleski AM
    Rev Col Bras Cir; 2012 Apr; 39(2):86-92. PubMed ID: 22664513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive power of progesterone receptor status in early breast carcinoma.
    Sutton R; Campbell M; Cooke T; Nicholson R; Griffiths K; Taylor I
    Br J Surg; 1987 Mar; 74(3):223-6. PubMed ID: 3567519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].
    Petru E; Beck K; Schünemann H; Schmähl D
    Wien Med Wochenschr; 1991; 141(7):133-5. PubMed ID: 2058160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
    Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP
    Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen.
    Bezwoda WR; Esser JD; Dansey R; Kessel I; Lange M
    Cancer; 1991 Aug; 68(4):867-72. PubMed ID: 1855186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic value of oestrogen receptors in breast cancer.
    Mercer RJ; Bryan RM; Bennett RC; Rennie GC; Lie TH; Morgan FJ
    Aust N Z J Surg; 1984 Feb; 54(1):7-10. PubMed ID: 6586172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oestrogen receptor assay in primary breast cancer: clinical validation and prognostic value.
    Furnival CM; Hillyard NC; Gough IR
    Aust N Z J Surg; 1982 Aug; 52(4):403-8. PubMed ID: 6956317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid hormone receptors in breast tumours presenting during pregnancy or lactation.
    Holdaway IM; Mason BH; Kay RG
    J Surg Oncol; 1984 Jan; 25(1):38-41. PubMed ID: 6694391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
    Alanko A; Heinonen E; Scheinin TM; Tolppanen EM; Vihko R
    Br J Cancer; 1984 Nov; 50(5):667-72. PubMed ID: 6498064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.